Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
2024 · Frontiers in Immunology · 12 citations
https://doi.org/10.3389/fimmu.2024.1350470
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
578
Citations
13
h-index
17
i10-index
Falk Heidenreich is an academic researcher from Los Angeles Clinical Trials. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 13, co-authored 38 publications.
ORCID: 0000-0001-8525-2810Click to start Chat